PortfoliosLab logoPortfoliosLab logo
AMCR vs. WST
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AMCR vs. WST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amcor plc (AMCR) and West Pharmaceutical Services, Inc. (WST). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AMCR achieves a -6.58% return, which is significantly lower than WST's 16.41% return.


AMCR

1D
-0.81%
1M
-3.71%
YTD
-6.58%
6M
-5.56%
1Y
-11.82%
3Y*
-3.84%
5Y*
-4.35%
10Y*

WST

1D
1.67%
1M
-1.89%
YTD
16.41%
6M
19.03%
1Y
42.78%
3Y*
-2.54%
5Y*
-0.73%
10Y*
15.79%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AMCR vs. WST - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
AMCR
Amcor plc
-6.58%-6.17%2.61%-14.97%3.20%6.16%13.41%-0.71%
WST
West Pharmaceutical Services, Inc.
16.41%-15.73%-6.75%49.97%-49.70%65.88%89.05%24.85%

Correlation

The correlation between AMCR and WST is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.29

Correlation (5Y)
Calculated over the trailing 5-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Jun 12, 2019

0.33

Fundamentals

Market Cap

AMCR:

$17.54B

WST:

$23.15B

EPS

AMCR:

$1.59

WST:

$7.47

PE Ratio

AMCR:

23.84

WST:

42.80

PS Ratio

AMCR:

0.73

WST:

7.21

PB Ratio

AMCR:

0.47

WST:

7.74

Total Revenue (TTM)

AMCR:

$22.19B

WST:

$3.22B

Gross Profit (TTM)

AMCR:

$4.10B

WST:

$1.17B

EBITDA (TTM)

AMCR:

$2.58B

WST:

$799.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AMCR vs. WST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMCR
AMCR Risk / Return Rank: 2525
Overall Rank
AMCR Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
AMCR Sortino Ratio Rank: 2424
Sortino Ratio Rank
AMCR Omega Ratio Rank: 2424
Omega Ratio Rank
AMCR Calmar Ratio Rank: 2727
Calmar Ratio Rank
AMCR Martin Ratio Rank: 2727
Martin Ratio Rank

WST
WST Risk / Return Rank: 7373
Overall Rank
WST Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
WST Sortino Ratio Rank: 7777
Sortino Ratio Rank
WST Omega Ratio Rank: 7474
Omega Ratio Rank
WST Calmar Ratio Rank: 7373
Calmar Ratio Rank
WST Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMCR vs. WST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amcor plc (AMCR) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AMCRWSTDifference
Sharpe ratioReturn per unit of total volatility

-1.43

Sortino ratioReturn per unit of downside risk

-2.38

Omega ratioGain probability vs. loss probability

0.96

1.24

-0.29

Calmar ratioReturn relative to maximum drawdown

-0.45

1.74

-2.19

Martin ratioReturn relative to average drawdown

-0.81

3.48

-4.29

AMCR vs. WST - Sharpe Ratio Comparison

The current AMCR Sharpe Ratio is -0.38, which is lower than the WST Sharpe Ratio of 1.05. The chart below compares the historical Sharpe Ratios of AMCR and WST, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


AMCRWSTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.38

1.05

-1.43

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.17

-0.02

-0.16

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.46

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.03

0.39

-0.42

Drawdowns

AMCR vs. WST - Drawdown Comparison

The maximum AMCR drawdown since its inception was -47.21%, smaller than the maximum WST drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for AMCR and WST.


Loading charts...

Drawdown Indicators


AMCRWSTDifference

Max Drawdown

Largest peak-to-trough decline

-47.21%

-59.29%

+12.08%

Max Drawdown (1Y)

Largest decline over 1 year

-26.51%

-24.70%

-1.81%

Max Drawdown (3Y)

Largest decline over 3 years

-29.92%

-53.79%

+23.87%

Max Drawdown (5Y)

Largest decline over 5 years

-34.24%

-59.29%

+25.05%

Max Drawdown (10Y)

Largest decline over 10 years

-59.29%

Current Drawdown

Current decline from peak

-31.09%

-31.34%

+0.25%

Average Drawdown

Average peak-to-trough decline

-14.54%

-16.88%

+2.34%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.67%

12.32%

+2.35%

Volatility

AMCR vs. WST - Volatility Comparison

Amcor plc (AMCR) has a higher volatility of 9.21% compared to West Pharmaceutical Services, Inc. (WST) at 7.76%. This indicates that AMCR's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AMCRWSTDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.21%

7.76%

+1.45%

Volatility (6M)

Calculated over the trailing 6-month period

25.29%

25.25%

+0.04%

Volatility (1Y)

Calculated over the trailing 1-year period

31.26%

41.20%

-9.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.00%

40.57%

-15.57%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.22%

34.63%

-5.41%

Dividends

AMCR vs. WST - Dividend Comparison

AMCR's dividend yield for the trailing twelve months is around 6.84%, more than WST's 0.27% yield.


PositionTTM20252024202320222021202020192018201720162015
AMCR
Amcor plc
6.84%6.15%5.34%5.11%4.05%3.93%3.93%2.17%0.00%0.00%0.00%0.00%
WST
West Pharmaceutical Services, Inc.
0.27%0.31%0.25%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%

Financials

AMCR vs. WST - Financials Comparison

This section allows you to compare key financial metrics between Amcor plc and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B2.00B3.00B4.00B5.00B6.00B20222023202420252026
5.91B
844.90M
(AMCR) Total Revenue
(WST) Total Revenue
Values in USD except per share items

AMCR vs. WST - Profitability Comparison

The chart below illustrates the profitability comparison between Amcor plc and West Pharmaceutical Services, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%25.0%30.0%35.0%40.0%20222023202420252026
20.1%
35.1%
Portfolio components
AMCR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amcor plc reported a gross profit of 1.19B and revenue of 5.91B. Therefore, the gross margin over that period was 20.1%.

WST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, West Pharmaceutical Services, Inc. reported a gross profit of 296.40M and revenue of 844.90M. Therefore, the gross margin over that period was 35.1%.

AMCR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amcor plc reported an operating income of 461.00M and revenue of 5.91B, resulting in an operating margin of 7.8%.

WST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, West Pharmaceutical Services, Inc. reported an operating income of 177.10M and revenue of 844.90M, resulting in an operating margin of 21.0%.

AMCR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amcor plc reported a net income of 278.00M and revenue of 5.91B, resulting in a net margin of 4.7%.

WST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, West Pharmaceutical Services, Inc. reported a net income of 138.80M and revenue of 844.90M, resulting in a net margin of 16.4%.


Frequently Asked Questions


AMCR and WST have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AMCR has higher volatility (9.21%) compared to WST (7.76%). In terms of maximum drawdown, AMCR dropped -47.21% vs WST's -59.29%.

WST currently has the higher Sharpe Ratio (1.05 vs -0.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AMCR and WST

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer